Nguyen NT, Raetz A, Montoya D, Schilling V, et al. Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers. Gynecol Oncol 2023;178:69-79.
PMID: 37806229